Financhill
Back

Evaxion AS 10K Form

Sell
20

EVAX
Evaxion AS

Last Price:
$5.37
Seasonality Move:
-49.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EVAX News And Ratings

See the #1 stock for the next 7 days that we like better than EVAX

EVAX Financial Statistics

Sales & Book Value

Annual Sales: $3.3M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.99
Price / Book: 1.74

Profitability

EPS (TTM): -6.99480
Net Income (TTM): $-12M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: -69.51%

Evaxion AS Earnings Forecast

Key Evaxion AS Financial Ratios

  • The Gross Profit Margin over the past 7 years for EVAX is 0.00%.
  • The Selling, General & Administrative Expenses for EVAX have been equal to 227.84% of Gross Profit Margin.
  • The Research & Development expenses have been 303.59% of Revenue.
  • The Net Earning history of EVAX is -316.00% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 2 years.

Evaxion AS Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: EVAX
Website: evaxion-biotech.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.8
Quick Ratio: 2.8

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 24

EVAX Technical Analysis vs Fundamental Analysis

Sell
20
Evaxion AS (EVAX) is a Sell

Is Evaxion AS a Buy or a Sell?

  • Evaxion AS stock is rated a Sell
    The current Evaxion AS [EVAX] share price is $5.10. The Score for EVAX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.